Severe leucopenia associated with sitagliptin use

Dario Pitocco; Francesco Zaccardi; F Martini; Giuseppe Scavone; Tittania Musella; Salvatore Caputo; Giovanni Ghirlanda

Severe leucopenia associated with sitagliptin use

Dario Pitocco, Francesco Zaccardi, F Martini, Giuseppe Scavone, Tittania Musella, Salvatore Caputo, Giovanni Ghirlanda

Risultato della ricerca: Contributo in rivista › Articolo › peer review

Abstract

We report the case of a type 2 diabetes subject who developed severe leucopenia associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor Sitagliptin and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment.

Lingua originale	Inglese
pagine (da-a)	30-32
Numero di pagine	3
Rivista	Diabetes Research and Clinical Practice
Volume	91
Stato di pubblicazione	Pubblicato - 2011

Keywords

Leucopenia
Sitagliptin

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{80f6637f25714a2489aba89072fd1e76,

title = "Severe leucopenia associated with sitagliptin use",

abstract = "We report the case of a type 2 diabetes subject who developed severe leucopenia associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor Sitagliptin and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment.",

keywords = "Leucopenia, Sitagliptin, Leucopenia, Sitagliptin",

author = "Dario Pitocco and Francesco Zaccardi and F Martini and Giuseppe Scavone and Tittania Musella and Salvatore Caputo and Giovanni Ghirlanda",

year = "2011",

language = "English",

volume = "91",

pages = "30--32",

journal = "Diabetes Research and Clinical Practice",

issn = "0168-8227",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Severe leucopenia associated with sitagliptin use

AU - Pitocco, Dario

AU - Zaccardi, Francesco

AU - Martini, F

AU - Scavone, Giuseppe

AU - Musella, Tittania

AU - Caputo, Salvatore

AU - Ghirlanda, Giovanni

PY - 2011

Y1 - 2011

N2 - We report the case of a type 2 diabetes subject who developed severe leucopenia associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor Sitagliptin and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment.

AB - We report the case of a type 2 diabetes subject who developed severe leucopenia associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor Sitagliptin and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment.

KW - Leucopenia

KW - Sitagliptin

KW - Leucopenia

KW - Sitagliptin

UR - http://hdl.handle.net/10807/13833

M3 - Article

SN - 0168-8227

VL - 91

SP - 30

EP - 32

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

ER -

Severe leucopenia associated with sitagliptin use

Abstract

Keywords

OSS delle Nazioni Unite

Altri file e collegamenti

Fingerprint

Cita questo